Dummer R, Sandhu S, Miller WH, Butler MO, et al. Longitudinal Genomic Analysis to Fine-Tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients With BRAF V600-Mutant Metastatic Melanoma. Clin Cancer Res 2025 Mar 19. doi: 10.1158/1078-0432.CCR-24-0254.
PMID: 40106536